Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Schirmer, M; Dejaco, C; Schmidt, WA.
Giant-cell arteritis: update: diagnosis and therapy].
Z Rheumatol. 2012; 71(9):754-759 Doi: 10.1007/s00393-012-0983-y
Web of Science PubMed FullText FullText_MUG

 

Co-authors Med Uni Graz
Dejaco Christian
Altmetrics:

Dimensions Citations:

Plum Analytics:

Scite (citation analytics):

Abstract:
Giant-cell arteritis (GCA) is the most common form of vasculitis in patients over 50 years old. Loss of vision is the most common severe complication but involvement of extracranial arteries including the aorta is more frequent than previously assumed. The role of dendritic and T-cells indicates the presence of an antibody but a clear association with underlying infections has not yet been demonstrated. Even if the inflammation parameters in blood are mostly increased in the diagnosis of GCA, specific laboratory tests for the diagnosis of GCA are not available. Of the imaging procedures ultrasonography, magnetic resonance imaging and (18)F-fluorodeoxyglucose positron emission tomography can be useful to localize and estimate the extent of vascular involvement. Glucocorticoids are still the standard therapy of GCA, whereby the cumulative dose can possibly be reduced by additional methotrexate. In addition acetylsalicylic acid is recommended as prophylaxis against cardiovascular and cerebrovascular events as well as prophylaxis and therapy of accompanying osteoporosis.
Find related publications in this database (using NLM MeSH Indexing)
Adrenal Cortex Hormones - therapeutic use
Anti-Inflammatory Agents - therapeutic use
Anti-Inflammatory Agents, Non-Steroidal - therapeutic use
Blindness - diagnosis
Diagnostic Imaging - methods
Giant Cell Arteritis - complications
Humans -

Find related publications in this database (Keywords)
Giant cell arteritis
Disease activity
Aortic aneurysm
Corticosteroids
Sonography
© Med Uni GrazImprint